Dr. Gary Lee Clayman, DMD, MD

Dr. Clayman practices at HCA Florida South Tampa Hospital in Tampa, Florida, part of HCA Healthcare.

Dr. Clayman's NPI, 1902905219, was assigned on September 22, 2006. Dr. Clayman graduated from Northeast Ohio Medical University in 1986. Dr. Clayman holds Florida license ME125739.

Dr. Clayman's primary practice is HCA Florida South Tampa Hospital, at 2901 W Swann Ave, Tampa, FL 33609 in Hillsborough County. The practice phone is (813) 873-6400.

Dr. Clayman's primary practice is HCA Florida South Tampa Hospital in Tampa, Florida, part of HCA Healthcare. The medical group on file is Clayman Thyroid Center. Dmand AI also links Dr. Clayman to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clayman practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Clayman's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Clayman is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Clayman's licenses on file in 4 states: Florida, Texas, California and Minnesota.

Dmand AI lists thyroid surgery among the conditions Dr. Clayman treats.

CMS data shows 471 Medicare services from Dr. Clayman across 8 procedure codes in 2024, for 202 Medicare patients. Medicare paid $141,605 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 202 Medicare patients who saw Dr. Clayman in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Clayman's median patient age at 60, with 74% women.

In 2024, Dr. Clayman wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $324 in total drug cost. In 2017, CMS named 87 claims across 3 drugs.

Dr. Clayman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 204 papers to Dr. Clayman, published from 2004 to 2024. 2010 was the busiest year, with 5. The most frequent topics are Carcinoma, Squamous Cell, Head and Neck Neoplasms and Thyroid Neoplasms. Dr. Clayman has published most often in Head Neck. Dr. Clayman's most frequent co-authors are Adel K. El-Naggar, MD, PhD, Scott M. Lippman, MD and Helmuth Goepfert, MD.

Dmand AI links Dr. Clayman to 3 clinical trials. Conditions studied include Mouth Neoplasms, Neoplasms, Squamous Cell and Tongue Neoplasms.

CMS Open Payments shows 21 general payments to Dr. Clayman from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Sanofi and Genzyme US Companies paid the most, $1,737. It also lists 2 research payments totaling $75 in 2019.

Dmand AI lists 6 awards for Dr. Clayman, most recently America's Top Doctors in 2014.

Dr. Clayman graduated from Northeast Ohio Medical University in 1986. Dr. Clayman is a member of NHS and ACS.

Dr. Clayman is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.